Article

Details released: Pharmacia donates latanoprost for study

Peapack, NJ-Pharmacia Ophthalmology donated latanoprost ophthalmic solution (Xalatan) to the National Eye Institute for use in the Ocular Hypertension Treatment Study (OHTS).

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Subscribe Now!
Related Videos
(Image credit: Ophthalmology Times) CCOI sets the stage for global ophthalmic innovation at Stanford Summit on July 23
(Image credit: Ophthalmology Times) Accelerating eye health innovation through CCOI – Stanford Summit
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game (Part 2)
Related Content
Alteogen receives positive CHMP opinion for aflibercept biosimilar, EYLUXVI
July 28th 2025

Alteogen receives positive CHMP opinion for aflibercept biosimilar, EYLUXVI

3 Things You Should Know About the GA Pipeline
June 4th 2025

3 Things You Should Know About Interventional Glaucoma Comanagement

CORXEL submits NDA for LNZ100 in China for presbyopia treatment
July 28th 2025

CORXEL submits NDA for LNZ100 in China for presbyopia treatment

Patient-Centered Treatment Strategies in the Management of nAMD and DME
May 30th 2025

Patient-Centered Treatment Strategies in the Management of nAMD and DME

Aldeyra Therapeutics receives orphan designation for ADX-2191 from EMA
July 26th 2025

Aldeyra Therapeutics receives orphan designation for ADX-2191 from EMA

Most Americans avoid eye exams due to perceived non-urgency, confusion about benefits
July 26th 2025

Most Americans avoid eye exams due to perceived non-urgency, confusion about benefits

© 2025 MJH Life Sciences

All rights reserved.